Des-enkephalin-γ-endorphin (DEγE): Biotransformation in rat, dog and human plasma

[1]  J. W. Nispen,et al.  Synthesis of fragments of human β-lipotropin, βh-LPH. Part VI. The synthesis of des-1-tyrosine-α-endorphin and shortened peptides† , 2010 .

[2]  J. Verhoef,et al.  Des-enkephalin-gamma-endorphin (DE gamma E): pharmacokinetics in dogs after intravenous and subcutaneous administration. , 1989, European journal of drug metabolism and pharmacokinetics.

[3]  J. Verhoef,et al.  [3H]9-desglycinamide,8-arginine vasopressin: metabolism and in-vivo fate. , 1986, The Journal of endocrinology.

[4]  P. A. Melgers,et al.  Ion-pair high-performance liquid chromatography separation of β-endorphin-(6–17) from fourteen fragments , 1986 .

[5]  J. Verhoef,et al.  Des-enkephalin-γ-endorphin: bioavailability in rats following the subcutaneous and intramuscular route of administration , 1986, Regulatory Peptides.

[6]  J. Verhoef,et al.  Des-Tyr1-γ-endorphin (DTγE) and des-enkephalin-γ-endorphin (DEγE): Plasma profile and brain uptake after systemic administration in the rat , 1985, Peptides.

[7]  W. Lehmann,et al.  Specific radioactivity determinations of ionic organic compounds of high specific activity by fast atom bombardment and field desorption mass spectrometry , 1984 .

[8]  F. Kaspersen,et al.  Synthesis and analysis of tritiated neuropeptides , 1984 .

[9]  D. de Wied,et al.  Effect of des-Tyr1-gamma-endorphin and des-enkephalin-gamma-endorphin on active and passive avoidance behavior of rats; a dose-response relationship study. , 1982, European journal of pharmacology.

[10]  W. Verhoeven,et al.  Antipsychotic Properties of Des-Enkephalin-γ-Endorphin in Treatment of Schizophrenic Patients , 1982 .

[11]  W. Verhoeven,et al.  Antipsychotic properties of Des-enkephalin-gamma-endorphin in treatment of schizophrenic patients. , 1982, Archives of general psychiatry.

[12]  G. Kovacs,et al.  Selective attenuation of passive avoidance behaviour by microinjection of beta-LPH62-77 and beta-LPH66-77 into the nucleus accumbens in rats. , 1982, Neuropharmacology.

[13]  J. Burbach,et al.  Proteolytic conversion of beta-endorphin by brain synaptic membranes. Characterization of generated beta-endorphin fragments and proposed metabolic pathway. , 1981, The Journal of biological chemistry.

[14]  W. Verhoeven,et al.  Neuroleptic-like and antipsychotic effects of gamma-type endorphins. , 1981, Modern problems of pharmacopsychiatry.

[15]  J. Burbach,et al.  Conversion of des-tyrosine-gamma-endorphin by brain synaptic membrane associated peptidases: identification of generated peptide fragments. , 1980, Biochemical and biophysical research communications.

[16]  J. Verhoef,et al.  H-Pro-[3H]Leu-Gly-NH2: metabolism in human and rat plasma investigated by high-pressure liquid chromatography. , 1980, Neuroendocrinology.

[17]  D. Wied,et al.  Neuroleptic-like activity of peptides related to [DES-TYR1] ?-endorphin: Structure activity studies , 1980 .

[18]  J. W. Nispen,et al.  Synthesis of fragments of human β‐lipotropin, βh‐LPH. Part IV*. The synthesis of shortened peptides related to des‐1‐tyrosine‐γ‐endorphin [β‐LPH‐(62‐77)] , 1980 .

[19]  J. W. Nispen,et al.  Synthesis of fragments of human β-lipotropin, βh-LPH. Part I. The synthesis of β-LPH-(61-76) and β-LPH-(61-77), i.e. α- and γ-endorphin, respectively , 1980 .

[20]  J. Verhoef,et al.  In vivo fate of a behaviorally active ACTH 4-9 analog in rats after systemic administration , 1976, Pharmacology Biochemistry and Behavior.

[21]  N. Marks,et al.  Significant Differences in the Degradation of Pro-Leu-Gly-NH2 by Human Serum and that of Other Species 1 , 1975, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.